small molecule

OXYBUTYNIN CHLORIDE

OXYBUTYNIN CHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyAmneal Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameOXYBUTYNIN CHLORIDE
Active ingredientOXYBUTYNIN CHLORIDE
Strength5MG
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalNovember 2015
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.